Ipca Labratories shares on Thursday jumped over 5 per cent after the company reported a 63.27 per cent rise in consolidated net profit in the September 30 ended quarter.
The scrip climbed 5.17 per cent to close at Rs 1,062.65 on the BSE. During the trade, it advanced 9.16 per cent to Rs 1,103 -- its 52-week high.
On the NSE, it rose 4.93 per cent to close at Rs 1,061.
Ipca Labratories on Thursday reported a 63.27 per cent rise in consolidated net profit at Rs 193.54 crore in the second quarter ended September 30.
The company had posted a consolidated net profit of Rs 118.54 crore in the same period last fiscal, Ipca Laboratories said in a regulatory filing.
Revenue from operations during the period under review stood at Rs 1,283.9 crore as against Rs 1,012 crore in the year-ago quarter, it added.
During the second quarter, revenue of domestic formulations business grew 16 per cent to Rs 543.21 crore as compared to Rs 468.62 crore in the corresponding period a year ago, the company said.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)